Development and Validation of a GC/MS Method for Simultaneous Determination of 7 Monoterpens in Two Commercial Pharmaceutical Dosage Forms
Authors
Abstract:
Terpenes are active constituents of many pharmaceutical dosage forms with naturalproducts origin. One of the challenges in developing dosage forms with herbal originis their standardization as pharmaceutical products. GC-Mass is the most decisive andreliable technique to fulfill the requirements in this regard. In the present study, a reliable,rapid, and accurate method was developed for determination of 7 monoterpenoids in twoselected pharmaceutical dosage forms (rowatinex and rowachol soft gelatin capsules) by gaschromatography-mass spectrometry triple quadrupole selected ion monitoring GC/MS-TQSIM.The method was validated for various parameters such as precision, linearity, accuracy,solution stability, limit of detection, and quantification. The average recovery of terpens wasin the range of 91.6-105.7%. The method was proved to be repeatable with RSD in the rangeof 0.28-11.18 for all of the concentration levels. The developed method is simple, rapid, andsensitive and was applied for determination of alpha pinene, camphene, beta pinene, cineol,fenchone, borneol, trans-anethol and menthol in a few batches of rowachol and rowatinexcapsules purchased from local drug stores.
similar resources
Validated Spectrophtometric Method for Simultaneous Determination of Bupernorphine and Naloxone in Pharmaceutical Dosage Forms
Buprenorphine is a partial mu agonist and kappa antagonist which is used for the treatment of pain and opioid addiction. A mixture of buprenorphine hydrochloride and naloxone hydrochloride has been approved for the treatment of opioid dependence.In this study a third order derivative spectrophotometric method based on zero-crossing technique has been used for the simultaneous determination of b...
full textRP-HPLC method development and validation for determination of eptifibatide acetate in bulk drug substance and pharmaceutical dosage forms
A new, rapid, economical and isocratic reverse phase high performance liquid chromatography (RP-HPLC) method was developed for the determination of eptifibatide acetate, a small synthetic antiplatelet peptide, in bulk drug substance and pharmaceutical dosage forms. The developed method was validated as per of ICH guidelines. The chromatographic separation was achieved isocratically on C18 colum...
full textValidated Spectrophtometric Method for Simultaneous Determination of Bupernorphine and Naloxone in Pharmaceutical Dosage Forms
Buprenorphine is a partial mu agonist and kappa antagonist which is used for the treatment of pain and opioid addiction. A mixture of buprenorphine hydrochloride and naloxone hydrochloride has been approved for the treatment of opioid dependence.In this study a third order derivative spectrophotometric method based on zero-crossing technique has been used for the simultaneous determination of b...
full textRP-HPLC method development and validation for determination of eptifibatide acetate in bulk drug substance and pharmaceutical dosage forms
A new, rapid, economical and isocratic reverse phase high performance liquid chromatography (RP-HPLC) method was developed for the determination of eptifibatide acetate, a small synthetic antiplatelet peptide, in bulk drug substance and pharmaceutical dosage forms. The developed method was validated as per of ICH guidelines. The chromatographic separation was achieved isocratically on C18 colum...
full textA Stability Indicating HPLC Method for the Determination of Fluvoxamine in Pharmaceutical Dosage Forms
Fluvoxamine maleate is a selective serotonin reuptake inhibitor, which is used for the treatment of different types of depressive disorders. In the present study, a stability indicating HPLC method was developed and validated for the determination of fluvoxamine maleate. The chromatographic separation was carried out using a Nova-Pak CN column and a mixture of K2HPO4 50 mM (pH 7.0) and acetonit...
full textMy Resources
Journal title
volume 17 issue Special Issue 2
pages 24- 32
publication date 2018-12-01
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023